These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22287766)

  • 1. Complete pathological response after sequential therapy with sunitinib and radiotherapy for metastatic clear cell renal carcinoma.
    Venton G; Ducournau A; Gross E; Lechevallier E; Rochwerger A; Curvale G; Zink JV; Salas S; Deville JL
    Anticancer Res; 2012 Feb; 32(2):701-5. PubMed ID: 22287766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of Sunitinib Rechallenge in Metastatic Renal Cell Carcinoma : A Case Report].
    Yoshinaga A; Kamata S
    Hinyokika Kiyo; 2015 May; 61(5):201-5. PubMed ID: 26087822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Therapy for Renal Cell Carcinoma.
    Joshi R; Rawal S
    JNMA J Nepal Med Assoc; 2015; 53(198):83-8. PubMed ID: 26994026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent treatment with sunitinib may achieve complete response in metastatic renal cell carcinoma.
    Aksu G; Ensaroglu F; Dolasik I; Temiz S; Halis H; Sener SY; Kaya A; Uygun K
    J BUON; 2010; 15(4):798-9. PubMed ID: 21229650
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapid improvement in pain and functional level in a patient with metastatic renal cell carcinoma: a case report and review of the literature.
    Hird AE; Chow E; Ehrlich L; Probyn L; Sinclair E; Yip D; Ko YJ
    J Palliat Med; 2008 Oct; 11(8):1156-61. PubMed ID: 18980461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sunitinib treatment for patients with advanced clear-cell renal-cell carcinoma after progression on sorafenib.
    Zimmermann K; Schmittel A; Steiner U; Asemissen AM; Knoedler M; Thiel E; Miller K; Keilholz U
    Oncology; 2009; 76(5):350-4. PubMed ID: 19321976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Brain metastasis which appeared during complete response of lung metastatic lesion by sunitinib treatment in a patient with renal cell carcinoma].
    Morizawa Y; Momose H; Toyoshima Y; Takada S; Fujimoto K; Oyama N
    Hinyokika Kiyo; 2013 Dec; 59(12):791-3. PubMed ID: 24419011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic collecting duct carcinoma of the kidney treated with sunitinib.
    Tazi EM; Essadi I; Tazi MF; Ahellal Y; M'rabti H; Errihani H
    World J Surg Oncol; 2011 Jul; 9():73. PubMed ID: 21752265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant sunitinib effectiveness in T4 renal clear cell carcinoma: a case report.
    Ricciardulli S; Del Biondo D; Cicero C; Leo G; Zeccolini G; Celia A
    Urologia; 2015; 82(2):109-13. PubMed ID: 25050998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of sunitinib in patients with renal cell carcinoma with bone metastases.
    Paule B; Brion N
    Anticancer Res; 2010 Dec; 30(12):5165-8. PubMed ID: 21187506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofractionated radiotherapy with concomitant sunitinib - is there a radiosensitizing effect?
    Taussky D; Soulières D
    Can J Urol; 2009 Apr; 16(2):4599-600. PubMed ID: 19364436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sunitinib in advanced metastatic non-clear cell renal cell carcinoma: a single institution retrospective study.
    Paglino C; Imarisio I; Ganini C; Morbini P; Vercelli A; Bregant C; Porta C
    Future Oncol; 2012 Dec; 8(12):1605-12. PubMed ID: 23231522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifocal brain metastases in clear cell renal cell carcinoma with complete response to sunitinib.
    Zeng H; Li X; Yao J; Zhu Y; Liu J; Yang Y; Qiang W
    Urol Int; 2009; 83(4):482-5. PubMed ID: 19996660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchial fistula associated with sunitinib in a patient previously treated with radiation therapy.
    Basille D; Andrejak M; Bentayeb H; Kanaan M; Fournier C; Lecuyer E; Boutemy M; Garidi R; Douadi Y; Dayen C
    Ann Pharmacother; 2010 Feb; 44(2):383-6. PubMed ID: 20118139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression level of vascular endothelial growth factor receptor-2 in radical nephrectomy specimens as a prognostic predictor in patients with metastatic renal cell carcinoma treated with sunitinib.
    Terakawa T; Miyake H; Kusuda Y; Fujisawa M
    Urol Oncol; 2013 May; 31(4):493-8. PubMed ID: 21478036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete response to sunitinib in a patient with relapsed irresectable renal cell carcinoma.
    Vaz MA; Pachón V; Grande E; Ferreiro R; Carrato A
    Anticancer Drugs; 2011 Sep; 22(8):817-21. PubMed ID: 21566523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sunitinib in patients with metastatic renal cell carcinoma.
    Motzer RJ; Rini BI; Bukowski RM; Curti BD; George DJ; Hudes GR; Redman BG; Margolin KA; Merchan JR; Wilding G; Ginsberg MS; Bacik J; Kim ST; Baum CM; Michaelson MD
    JAMA; 2006 Jun; 295(21):2516-24. PubMed ID: 16757724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sunitinib-induced nephrotic syndrome in association with drug response in a patient with Xp11.2 translocation renal cell carcinoma.
    Liu YC; Chang PM; Liu CY; Yang CY; Chen MH; Pan CC; Chen MH
    Jpn J Clin Oncol; 2011 Nov; 41(11):1277-81. PubMed ID: 21965162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term response with sunitinib for metastatic renal cell carcinoma.
    Ronnen EA; Kondagunta GV; Ginsberg MS; Russo P; Motzer RJ
    Urology; 2006 Sep; 68(3):672.e19-20. PubMed ID: 16979716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with metastatic renal cell carcinoma with long-term disease-free survival after treatment with sunitinib and resection of residual metastases.
    Rini BI; Shaw V; Rosenberg JE; Kim ST; Chen I
    Clin Genitourin Cancer; 2006 Dec; 5(3):232-4. PubMed ID: 17239278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.